| RS1381254564 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS138125827 |
CHRNG
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive multiple pterygium syndrome, Lethal multiple pterygium syndrome |
| RS138126912 |
PRF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 2, Inborn genetic diseases |
| RS138127105 |
MYH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy 14 |
| RS138127286 |
LRP6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Coronary artery disease |
| RS1381275842 |
INVS
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile nephronophthisis, Nephronophthisis |
| RS1381293874 |
KCNQ1
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS138129490 |
SMARCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nicolaides-Baraitser syndrome, Inborn genetic diseases |
| RS138130157 |
PRKAG3
|
Health Risk |
association |
SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS, SKELETAL MUSCLE GLYCOGEN CONTENT AND METABOLISM QUANTITATIVE TRAIT LOCUS |
| RS138131191 |
TPI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Triosephosphate isomerase deficiency, Triosephosphate isomerase deficiency |
| RS1381315419 |
USH1C
|
Health Risk |
Pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS138131967 |
AP4M1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 50, Hereditary spastic paraplegia 50 |
| RS138132026 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic kidney disease, Polycystic kidney disease 2 |
| RS1381325040 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS138133019 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS1381334911 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138133550 |
DNM1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Encephalopathy, lethal |
| RS138133926 |
TULP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1381341766 |
FERRY3
|
Health Risk |
Likely pathogenic |
— |
| RS138134718 |
AGL
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease type III, AGL-related disorder |
| RS138135177 |
CELSR2
|
Health Risk |
Conflicting classifications of pathogenicity |
CELSR2-related disorder, CELSR2-related disorder |
| RS138135248 |
COPB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1381368546 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS1381370500 |
WRN
|
Health Risk |
Likely pathogenic |
Werner syndrome, Werner syndrome |
| RS138137158 |
HDAC4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138137162 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS138137552 |
BCOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculofaciocardiodental syndrome, Oculofaciocardiodental syndrome |
| RS138137682 |
SLC4A11
|
Health Risk |
Conflicting classifications of pathogenicity |
Corneal dystrophy, Congenital hereditary endothelial dystrophy of cornea |
| RS138138436 |
ASPM
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 5, primary |
| RS138138689 |
USH1C
|
Health Risk |
Pathogenic |
Usher syndrome type 1C, Autosomal recessive nonsyndromic hearing loss 18A |
| RS1381392993 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Polyps |
| RS1381393162 |
FREM1
|
Health Risk |
Likely pathogenic |
— |
| RS1381409755 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS138141071 |
GOLGA3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138141099 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
FLNB-Related Spectrum Disorders, Inborn genetic diseases |
| RS138141427 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Permanent neonatal diabetes mellitus, Diabetes mellitus |
| RS138141474 |
OTOA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 22, OTOA-related disorder |
| RS1381421236 |
STXBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1381427322 |
CLN6
|
Health Risk |
Pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS1381434852 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS138143719 |
DTNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 1, Left ventricular noncompaction 1 |
| RS138143769 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1381447036 |
ITCH
|
Health Risk |
Pathogenic |
Syndromic multisystem autoimmune disease due to ITCH deficiency, Syndromic multisystem autoimmune disease due to ITCH deficiency |
| RS1381450738 |
PLEC
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS138145424 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Duchenne muscular dystrophy |
| RS1381469349 |
CFI
|
Health Risk |
Pathogenic/Pathogenic, low penetrance |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS138146982 |
SPAST
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1381478610 |
CASR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypocalciuric hypercalcemia, Autosomal dominant hypocalcemia 1 |
| RS1381481518 |
PROM1
|
Health Risk |
Pathogenic |
— |
| RS138148950 |
MRPS22
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia with lactic acidemia and hyperammonemia, MRPS22-related disorder |
| RS138148991 |
GALE
|
Health Risk |
Conflicting classifications of pathogenicity |
UDPglucose-4-epimerase deficiency, UDPglucose-4-epimerase deficiency |
| RS138149179 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS138149494 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138149656 |
DNAH9
|
Health Risk |
Pathogenic/Likely pathogenic |
DNAH9-related disorder, DNAH9-related disorder |
| RS1381506466 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS138151279 |
CEP152
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 9, primary |
| RS138151312 |
DNAH10
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1381516878 |
NTRK1
|
Health Risk |
Pathogenic |
Hereditary insensitivity to pain with anhidrosis, Hereditary insensitivity to pain with anhidrosis |
| RS1381519494 |
NAGA
|
Health Risk |
Pathogenic |
Alpha-N-acetylgalactosaminidase deficiency type 1, Alpha-N-acetylgalactosaminidase deficiency type 1 |
| RS138152469 |
SRCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
SRCAP-related disorder, SRCAP-related disorder |
| RS1381525157 |
EVC
|
Health Risk |
Pathogenic |
Curry-Hall syndrome, Ellis-van Creveld syndrome |
| RS138153104 |
CCDC50
|
Health Risk |
Conflicting classifications of pathogenicity |
CCDC50-related disorder, CCDC50-related disorder |
| RS138153246 |
GSN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS138153307 |
MLC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts |
| RS138154238 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Fraser syndrome 2 |
| RS138154934 |
ATP7A
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked distal spinal muscular atrophy type 3, Cutis laxa |
| RS138155461 |
TRPC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Sarcoma, Cervical cancer |
| RS138155747 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS138156311 |
ACSF3
|
Health Risk |
Pathogenic/Likely pathogenic |
Combined malonic and methylmalonic acidemia, ACSF3-related disorder |
| RS138156402 |
SLC7A9
|
Health Risk |
Conflicting classifications of pathogenicity |
SLC7A9-related disorder, Cystinuria |
| RS138156449 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, RYR1-related disorder |
| RS138156467 |
CSF3R
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive severe congenital neutropenia due to CSF3R deficiency, Inherited Immunodeficiency Diseases |
| RS138157153 |
CDK5RAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 3, primary |
| RS138157520 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, CPLANE1-related disorder |
| RS138157585 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS138157751 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS138157885 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS138158369 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 |
| RS138160033 |
SLC52A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Brown-Vialetto-van Laere syndrome 2, Inborn genetic diseases |
| RS138160928 |
FGD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4H |
| RS1381622639 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS138162760 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS1381634873 |
RPGRIP1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS138163892 |
PITX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial fibrillation, familial |
| RS1381641458 |
CTC1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS138164489 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Cardiovascular phenotype |
| RS138165832 |
PLOD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1381664827 |
TSFM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3, Fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3 |
| RS1381665298 |
UGDH
|
Health Risk |
Likely pathogenic |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS138166567 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, IFT140-related disorder |
| RS138167195 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS138167706 |
ABL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1381679718 |
MRE11
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia-like disorder, Ataxia-telangiectasia-like disorder 1 |
| RS1381679767 |
RYR1
|
Health Risk |
Pathogenic/Likely pathogenic |
RYR1-related disorder, Central core myopathy |
| RS1381684916 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS138168899 |
LAMA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS138169215 |
EXOSC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 1B, Pontocerebellar hypoplasia type 1B |
| RS1381701157 |
CTLA4
|
Health Risk |
Likely pathogenic |
Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency |
| RS138170393 |
MYBPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis, distal |
| RS138171306 |
PEX10
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder, complementation group 7 |